Efficacy and Safety of Mobocertinib in NSCLC Patients with EGFR Exon 20 Insertions

Time: 11:00 am
day: Day One


  • Overview of EGFR exon20 insertions in NSCLC and how they differ from common sensitizing EGFR mutations
  • Current challenges associated with targeting these alterations and theneed for effective therapies
  • Preclinical and clinical profile of Mobocertinib